RecruitingNot ApplicableNCT06109493
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Sponsor
Universidad Europea de Madrid
Enrollment
104 participants
Start Date
Nov 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Patients with chronic kidney disease on haemodialysis
- Older than 18 years-old
- At least 3 months on haemodialysis
- HADS Global Scale Score ≥14
Exclusion Criteria5
- Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
- Antidepressant drugs consume
- Insufficient understanding of Spanish.
- Patients who are in the Advanced Chronic Kidney Disease Unit
- Receiving other psychological treatment
Interventions
BEHAVIORALACT
Acceptance and Commitment Therapy methods were focused on promoting Values clarification, Acceptance, Cognitive defusion, Committed action and Flexible attention to the present moment, and included methods such as the Garden Metaphor, Funeral exercise or Mindfulness training.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06109493
Related Trials
Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT0659339212 locations
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
NCT053181961 location
Home Hospital for Suddenly Ill Adults
NCT035242222 locations